Horizon Therapeutics Ireland DAC vs. Geron Corporation – Trademark Extension of Time TTAB Proceeding 90658701

This Extension of Time was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on August 17, 2022 and assigned serial number 90658701 by the TTAB.

Plaintiff:
Horizon Therapeutics Ireland DAC represented by FRANCES M. JAGLA of CHRISTENSEN O’CONNOR JOHNSON KINDNESS PLLC.

Defendant:
Geron Corporation represented by ROCHELLE D. ALPERT of MORGAN, LEWIS & BOCKIUS LLP.
Trademark Information: TELRYZA – US Trademark Serial Number 90658701
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
August 17, 2022 – FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE
August 18, 2022 – EXT GRANTED
November 11, 2022 – FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE
November 11, 2022 – EXT GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *